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ABSTRACT: G-quadruplexes are nucleic acids structures stabilized by
physiological concentration of potassium ions. Because low stability G-
quadruplexes are hardly detectable by mass spectrometry, we optimized solvent
conditions: isopropanol in a triethylamine/hexaﬂuoroisopropanol mixture highly
increased G-quadruplex sensitivity with no modiﬁcation of the physiological G-
quadruplex conformation. G-quadruplexes/G-quadruplex-ligand complexes were
also correctly detected at concentration as low as 40 nM. Detection of the
physiological conformation of G4s and their complexes opens up the possibility
to perform high-throughput screening of G-quadruplex ligands for the
development of drug molecules eﬀective against critical human diseases.
G-quadruplexes (G4s) are noncanonical nucleic acidstructures, which form in guanine (G)-rich sequences
by G-quartet stacking, and are stabilized by potassium (K+), the
most relevant intracellular monovalent cation.1,2 G4s may
adopt diﬀerent conformations, i.e., parallel, antiparallel, or
hybrid, depending on their strand orientation.3 G4s are
involved in the modulation of important biological processes
in eukaryotes, prokaryotes, and viruses.4−11 In eukaryotes and
viruses, the use of G4-ligands has shown promising therapeutic
activity.12−15 Electrospray ionization (ESI) mass spectrometry
(MS) is a powerful tool to investigate both G4 structure and
G4/small molecule binding.16 To this aim, G4s need to
maintain their native conformation. The main problem is that
G4s are folded in physiological concentration of K+ (100−150
mM), which strongly hampers G4 detection and data quality in
ESI-MS. To circumvent this problem, diﬀerent approaches have
been developed: (i) substitution of K+ with the volatile NH4
+
ion, which ﬁts in the G4;17,18 however, G4s folded in NH4
+
often adopt nonphysiological conformations.19 (ii) G4 folding
in physiological concentration of K+ and removal of the
noncoordinated ions by ﬁltration or ethanol precipitation;20,21
this approach is suitable only for stable G4s with slow unfolding
kinetics in low K+ concentration. (iii) G4 folding in MS-
compatible amounts of K+ (<1 mM) in the presence of a
volatile bulky buﬀer (e.g., triethylammonium acetate (TEAA)
or trimethylammonium acetate (TMAA)22); the rationale is
that the bulky buﬀer does not ﬁt into the G4 cavity and thus it
does not prevent K+ from coordinating the G4, but it provides
physiological ionic strength. Using this approach we obtained
very good results in MS detection of stable G4s, but we
observed weak detection and resolution of low stability G4s.
We thus deemed it worth searching for new solvent conditions
to favorably compare with the TMAA-based method.
■ EXPERIMENTAL SECTION
Oligonucleotides. Oligonucleotides were purchased from
Sigma-Aldrich, Milan, Italy, and used without further
puriﬁcation. Five G4s were tested: two form in the human
immunodeﬁciency virus-1 (HIV-1) LTR promoter (LTR-III
and LTR-IV),8 one in the herpes simplex virus-1 (HSV-1)
genome (un2)12 and two in the human chromosome, at
telomeres (hTel) and in the promoter of the c-myc oncogene
(c-myc) (Table S1). Oligonucleotides (5 μM) in 1 mM KCl
(Fluka, St. Louis, MO), 150 mM trimethylammonium acetate
(TMAA) (Fluka) pH 7.4 (adjusted from pH ∼7 to 7.4 with
triethylamine (TEA) (Fisher, Pittsburgh, PA)) were annealed
by heating at 95 °C for 5 min, gradually cooled to room
temperature, added of 20% of isopropanol (IPA) (Carlo Erba
Reagenti S.p.A, Milan, Italy) or 20% of water and incubated
overnight at 4 °C (ﬁnal buﬀer composition, 0.8 mM KCl, 120
mM TMAA pH 7.4, (20% IPA)). Alternatively oligonucleotides
(5 μM) in 1 mM KCl, 150 mM of hexaﬂuoroisopropanol
(Across, Pittsburgh, PA) neutralized to pH 7.4 with TEA
(TEA/HFIP) were annealed by heating at 95 °C for 5 min,
gradually cooled to room temperature, added of 20% of IPA or
20% of water and incubated overnight at 4 °C (ﬁnal buﬀer
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composition: 0.8 mM KCl, 120 mM TEA/HFIP, pH 7.4, 20%
IPA). BRACO-19 (Endotherm Life Science, Saarbrücken,
Germany) was added to the annealed G4 at G4/compound
molar ratio 1:2 and incubated one more day before analysis.
Mass Spectrometry Analysis. Samples were analyzed by
direct infusion electrospray ionization (ESI) on a Xevo G2-XS
QTOF mass spectrometer (Waters, Manchester, U.K.). This is
a high-resolution instrument that allowed us to visualize the
isotopic pattern, identify the charge state, and therefore
unambiguously calculate the neutral mass of the detected
species. The injection was automatically performed by an
Agilent 1290 Inﬁnity HPLC (Agilent Technologies, Santa
Clara, CA) equipped with an autosampler; the carrying buﬀer
was TMAA 120 mM pH 7.4 with/without 20% IPA or TEA/
HFIP 120 mM pH 7.4 with/without 20% IPA. A volume of 5
μL of each sample were typically injected for each analysis. In
all experiments, ESI source settings were: electrospray capillary
voltage 1.8 kV; source and desolvation temperatures 45 and 65
°C, respectively; sampling cone voltage 65 V. All these
parameters ensured minimal fragmentation of the DNAs
complexes. The instrument was calibrated using a 2 mg/mL
solution of sodium iodide in 50% of IPA. Additionally, the use
of the LockSpray during analysis provided a typical <5 ppm
mass accuracy. The internal standard LockSpray consisted in a
solution of leu-enkephalin 1 μg/mL in acetonitrile/water
(50:50, v/v) containing 0.1% of formic acid. When comparing
the same samples in diﬀerent buﬀers, spectra were acquired the
same day to avoid signal decrease due to source contamination.
Circular Dichroism Analysis. CD spectra were recorded
on a Chirascan-Plus (Applied Photophysics, Leatherhead, U.K.)
equipped with a Peltier temperature controller set at 20 °C,
using a quartz cell of 5 mm optical path length, scanning at 1
nm bandwidth, 0.2 nm step size, and at 0.3 s per point over a
wavelength range of 230−320 nm. Observed ellipticities were
converted to molar ellipticity ([θ] = deg × cm2 × dmol−1).
Oligonucleotides (5 μM) in 1−100 mM KCl, 150 mM TMAA
(unless otherwise speciﬁed) or 20 mM potassium phosphate
(Sigma-Aldrich, St. Louis, MO) buﬀer pH 7.4 were annealed by
heating at 95 °C for 5 min, gradually cooled to room
temperature, added 20% of the indicated solvent (Sigma or
Carlo Erba) or 20% of water, and incubated overnight at 4 °C.
Oligonucleotides in TEA/HFIP were annealed as previously
discussed.
Figure 1. Analysis of the tested sequences in the diﬀerent buﬀers optimized for MS detection of the G4 structure. (a) Dichroic spectra of G4 folding
sequences in 100 mM K+, 20 mM K2HPO4, pH 7.4 (PB) (blue line), 0.8 mM K
+, 120 mM TMAA (red line), 0.8 mM K+, 120 mM TMAA added of
20% IPA (green line), 0.8 mM K+, TEA/120 mM HFIP added of 20% IPA (violet line). (b) ESI-MS spectra of the tested sequences in the buﬀers
indicated at the bottom. Spectra were zoomed to compare peaks with charge state that allows the highest relative intensity (RI) in TMAA buﬀer. (c)
Base peak intensity of the tested sequences in the indicated buﬀers. (d) Representative ESI-MS spectra (LTR-IV) to show the entire peak charge
distribution in the indicated buﬀers.
Analytical Chemistry Technical Note
DOI: 10.1021/acs.analchem.7b01282
Anal. Chem. 2017, 89, 8632−8637
8633
■ RESULTS AND DISCUSSION
The conformation of the viral (LTR-III, LTR-IV, un2) and
cellular (hTel and c-myc) G4s (Table S1) was initially tested.
In 100 mM K+, LTR-IV folds in a bulged parallel G423 with Tm
of 50 °C. LTR-III8 and hTel24 are hybrid G4 with Tm of 68 °C,
while c-myc and un2 display parallel and antiparallel topology,
respectively, and Tm > 90 °C.
12,25 To assess the G4
conformation of the tested sequences in diﬀerent buﬀer
conditions, circular dichroism (CD) was used (Figure S1a).
In 100 mM K+ and phosphate buﬀer, LTR-IV and c-myc
showed a parallel G4 CD signature with one maximum at 260
nm and one minimum at 240 nm. LTR-III and hTel displayed a
hybrid-like spectrum: LTR-III had a maximum at 260 nm and a
shoulder at 290 nm, hTel a maximum at 290 nm and a shoulder
at 250 nm; both structures displayed a minimum at 235−240
nm. Un2 displayed a typical antiparallel G4 structure with a
minimum at 260 and two maxima at 240 and 290 nm.26
Substitution of the phosphate buﬀer with trimethylammonium
acetate (TMAA) buﬀer, the cation of which is too bulky to ﬁt
the G4,22 did not lead to any CD-detectable structure
modiﬁcation, as long as the total ion concentration was
maintained constant and K+ was kept above 10 mM (Figure
S1a). When K+ concentration was reduced to 10 mM or below,
decreased molar ellipticity was observed for LTR-IV, indicating
less oligonucleotide folded into G4; yet the parallel
conformation was maintained. LTR-III remained at the same
fully folded conformation at both 100 and 10 mM K+, however
at 0.8 mM K+ the molar ellipticity dramatically decreased and a
structural change was monitored as inversion of relative peak
intensity at 260 and 290 nm. HTel displayed a similar pattern,
with identical CD spectra at 100 and 10 mM K+, turning into
the CD signature characteristic of an antiparallel structure at 0.8
mM K+. In contrast, the structures with higher Tm (i.e., c-myc
and un2) were poorly aﬀected by K+ decrease (Figure S1a).
These data indicate that low K+ concentration in TMAA is not
optimal for several G4s, since they undergo conformational
changes.
To perform MS of G4s maintaining stability and
conformation as close as possible to those in 100 mM K+, we
initially explored the eﬀect of organic solvents on G4-folding in
TMAA. It has been reported that the presence of primary
alcohols promotes G4-folding due to crowding eﬀect27 and to
water release during G4 assembly.28,29 Several organic solvents
in 120 mM TMAA and 0.8 mM K+ were tested by CD for their
eﬀectiveness in promoting the physiological G4 conformation
of LTR-IV. Isopropanol (IPA), acetonitrile, and methanol
proved to be the most eﬀective in stabilizing LTR-IV G4,
whereas ethanol was slightly less eﬃcient (Figure S1b). Molar
ellipticity substantially increased after addition of 20% organic
solvent to the TMAA solution with 0.8% K+, with the CD
spectrum becoming practically identical to that measured in
100 mM K+, conﬁrming the strong G4-folding-inducing
properties of organic solvents (Figure S1b). IPA, being less
toxic than methanol and acetonitrile, was chosen for further
MS-buﬀer optimization. Molar ellipticity of LTR-IV G4 was
proportional to the amount of solvent in the buﬀer, reaching a
plateau at 30% of IPA; at 20% IPA the CD spectrum of LTR-IV
G4 was similar to that measured in 100 mM K+ (Figure S1c),
Table 1. Relative Amounts of Free DNA (No K+) and K+ Adducts Detected by MS in TMAA and TEA/HFIP Buﬀers in the
Presence/Absence of 20% IPAa
intensity of K+-coordinated adducts
G4 buﬀer no K+ 1K+ 2K+ 3K+ 4K+ charge state base peak
LTR-IV
TMAA 53.5 ± 0.8 23.6 ± 1.0 12.2 ± 0.6 6.6 ± 0.4 4.1 ± 0.6 4−, 5− [G4]4−
TMAA/IPA 2.6 ± 0.8 4.4 ± 0.3 54.3 ± 2.1 26.3 ± 1.2 12.4 ± 0.6 4−, 5− [G4 + 2K+]4−
TEA/HFIP 50.6 ± 4.3 20.5 ± 2.5 20.3 ± 0.8 6.8 ± 0.9 1.8 ± 0.0 3− to 10− [G4]9−
TEA/HFIP/IPA 4.1 ± 0.5 0.5 ± 0.0 92.0 ± 0.1 3.0 ± 0.1 0.3 ± 0.0 3− to 9− [G4 + 2K+]7−
LTR-III
TMAA 34.4 ± 2.6 15.2 ± 0.8 23.0 ± 2.0 17.2 ± 2.3 10.3 ± 0.70 5− to 7− [G4 + 2K+]5−
TMAA/IPA 1.3 ± 0.12 1.9 ± 0.19 54.0 ± 6.0 27.4 ± 3.5 15.3 ± 2.8 5−, 6− [G4 + 2K+]5−
TEA/HFIP 42.2 ± 1.3 7.9 ± 1.1 41.1 ± 5.3 7.6 ± 1.3 0.0 ± 0.0 6− to 13− [G4]11−
TEA/HFIP/IPA 5.5 ± 0.9 1.4 ± 0.4 81.4 ± 1.6 10.6 ± 1.2 1.0 ± 0.6 5− to 12− [G4 + 2K+]8−
un2
TMAA 0.0 ± 0.0 0.0 ± 0.0 3.1 ± 0.15 72.7 ± 1.1 24.2 ± 1.3 5−, 6− [G4 + 3K+]5−
TMAA/IPA 0.0 ± 0.0 0.0 ± 0.0 4.8 ± 0.9 67.3 ± 0.8 27.8 ± 1.0 5−, 6− [G4 + 3K+]5−
TEA/HFIP 0.0 ± 0.0 0.0 ± 0.0 4.9 ± 0.9 80.4 ± 3.3 14.1 ± 2.6 6− to 9− [G4 + 3K+]8−
TEA/HFIP/IPA 1.7 ± 0.1 1.5 ± 0.0 12.5 ± 0.3 73.2 ± 0.3 11.1 ± 0.1 6− to 9− [G4 + 3K+]8−
hTel
TMAA 7.3 ± 1.2 39.8 ± 2.7 31.4 ± 1.6 13.9 ± 1.4 7.5 ± 1.5 4− to 6− [G4 + 2K+]4−
TMAA/IPA 0.0 ± 0.0 26.7 ± 1.6 44.5 ± 0.6 19.7 ± 1.0 9.1 ± 0.7 3− to 5− [G4 + 2K+]4−
TEA/HFIP 57.2 ± 6.7 8.9 ± 2.8 20.7 ± 2.1 12.6 ± 1.0 0.0 ± 0.0 4− to 10− [G4]9−
TEA/HFIP/IPA 27.3 ± 1.0 8.0 ± 0.0 62.4 ± 0.5 2.2 ± 0.6 0.0 ± 0.0 3− to 10− [G4 + 2K+]7−
c-myc
TMAA 0.0 ± 0.0 0.0 ± 0.0 61.3 ± 5.3 25.8 ± 1.6 12.8 ± 3.7 4− to 6− [G4 + 2K+]5−
TMAA/IPA 0.0 ± 0.0 0.0 ± 0.0 59.5 ± 2.6 26.4 ± 1.5 14.0 ± 1.3 4− to 6− [G4 + 2K+]5−
TEA/HFIP 0.0 ± 0.0 0.0 ± 0.0 52.0 ± 5.2 33.1 ± 2.5 14.0 ± 2.5 6− to 10− [G4 + 2K+]8−
TEA/HFIP/IPA 3.9 ± 0.4 1.2 ± 0.2 75.4 ± 0.2 19.4 ± 0.4 0.0 ± 0.0 4− to 11− [G4 + 2K+]8−
aIn bold is the intensity of the prevalent adduct in the corresponding sample. The numbers represent the intensity of the free DNA (no K) or K+
adducts (1K+, 2K+, 3K+, 4K+). The intensity is normalized to the sum of the intensities of all species (no K, 1K+, 2K+, 3K+, 4K+) and expressed in %.
All charge states present in the spectra were included in the calculation; charge states per each sample are indicated. Each sample was assayed at least
three times and standard deviation is reported. The base peak, i.e., the peak with the highest intensity within each spectrum, is shown.
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therefore 20% IPA was used in the following buﬀer
optimization process. The G4-stabilizing eﬀect of 20% IPA
was maintained also on LTR-III and hTel, whereas un2 and c-
myc were not modiﬁed (Figure 1a), in line with the previously
observed stability of these G4s (Figure S1a).
MS spectra in the presence/absence of IPA were obtained to
conﬁrm G4 folding by assessing the number of coordinated K+
ions, which are diagnostic for the number of G-quartets
involved in the G4 structure (Figure 1b and Figure S2). The
MS spectrum of LTR-IV in TMAA 0.8 mM K+ presented a
major peak corresponding to LTR-IV and peaks of lower
intensity that corresponded to LTR-IV-K+ adducts, which
displayed a salt concentration-dependent statistical distribution,
suggesting nonspeciﬁc K+ binding. The use of IPA drastically
modiﬁed the spectrum: the intensity of the free DNA and 1K+-
adduct became much lower compared to the 2K+-adduct. The
2K+-adduct is consistent with the reported structure of LTR-IV
G4, comprising three G-quartets coordinating two K+23. The
same rationale applies to LTR-III: in the absence of IPA the
peak of the free LTR-III and small amounts of 1K+- and 2K+-
adducts were present; upon addition of IPA, the peak
corresponding to the 2K+-adduct became the main peak and
those corresponding to the free LTR-III and 1K+-adducts
disappeared. The behavior of hTel DNA was more complex: in
the absence of IPA, hTel mainly showed 1K+- and 2K+-adducts,
consistently with formation of two and three G-quartets.
Addition of IPA increased the intensity of the 2K+-adduct
compared to the 1K+-adduct, which however remained intense.
These data are in line with the diﬀerent G4 conformations
adopted by the telomeric sequence, including “form 3” that
displays two G-quartets coordinating one K+.30 MS spectra of
un2 and c-myc showed the presence of a 3K+ and 2K+-adduct,
respectively, which is consistent with their reported G4
structures12,25 and IPA addition did not aﬀect K+-adduct
distribution (Figure 1b and Figure S2). Relative peak intensity
and K+-adduct distribution (Table 1) indicate that addition of
20% IPA positively inﬂuences MS detection of the least stable
G4s (i.e., LTR-IV, LTR-III, and hTel), whereas it does not
perturb the most stable G4s (i.e., un2 and c-myc).
The ability of triethylamine/hexaﬂuoroisopropanol (TEA/
HFIP) to improve MS detection of nucleic acids has been
described.31,32 We initially compared by CD the eﬀect of TEA/
HFIP/IPA vs TMAA/IPA on G4-folding. All oligonucleotides
essentially maintained the same conformation in TEA/HFIP/
IPA and TMAA/IPA (Figure 1a), with the exception of hTel,
which in TEA/HFIP/IPA increased at 265 nm and decreased at
250 nm. K+-adduct distribution in the two buﬀers was next
tested by ESI/MS (Figure 1b and Figure S2): all G4s displayed
similar MS spectra in the two buﬀers, with hTel representing
the only exception: in TEA/HFIP ± IPA, the peaks
corresponding to the 1K+-adduct almost disappeared. The
hTel 1K+-adduct likely represents hTel G4 form 3: in the same
buﬀer conditions, the CD spectrum exhibited a decrease of the
shoulder at 250 nm, reported as characteristic of hTel G4 form
3.30 K+-adduct distribution of the tested G4s in TEA/HFIP
buﬀer in the presence/absence of 20% IPA are summarized in
Table 1: as in the case of TMAA, the presence of IPA highly
increased detection of MS peaks corresponding to the fully
folded G4s, especially with the least stable G4s, i.e., LTR-IV,
LTR-III, and hTel. In TEA/HFIP/IPA, however, and in
contrast to what was observed in TMAA/IPA, peaks
corresponding to the folded G4 increased also for the most
stable G4s, i.e., un2 and c-myc. In general, peak intensity was
highly augmented in TEA/HFIP ± IPA: the most intense peak
(base peak) in each MS spectrum increased by 1 order of
magnitude in TEA/HFIP/IPA vs TMAA/IPA (Figure 1c). In
addition, charge distribution in TEA/HFIP and TMAA was
diﬀerent: for instance, LTR-IV in TEA/HFIP/IPA presented
peaks with charge states from 3− to 9−, whereas in TMAA/
IPA 4− and 5− charge states only were detected (Figure 1d).
K+ binding was not altered in TEA/HFIP/IPA buﬀer: more
than 95% of peaks with charge state 7− corresponded to LTR-
IV coordinated to two K+; when considering all charge states,
the intensity of 2K+-adducts, indicating full G4-folding,
represented more than 90% of the intensity of all peaks
(Table 1). Around 4% peak intensity corresponded to free
DNA, diagnostic of the unfolded oligonucleotide, and similar
percentage to multi-K+ or TEA adducts, mostly at lower charge
states (4−, 3−) (Figure 1d). Similar results were obtained for
LTR-III, c-myc, and un2 (Table 1). The hTel sequence showed
a diﬀerent behavior: in TEA/HFIP/IPA, around 62% of the
peaks corresponded to 2K+-adducts and 27% to free DNA
(Table 1). In contrast, in TMAA/IPA around 45% and 25% of
peaks corresponded to 2K+-and 1K+-adducts, respectively, and
no free DNA was detected, suggesting some conformational
diﬀerence of hTel in the two buﬀers. In general the high charge
peaks retained the G4-diagnostic K+, while aspeciﬁc salt-
adducts were absent, expediting the assignments of the correct
number of G-quartets. We ascribe the multicharge eﬀect to the
lower amount of R3NH
+ ions in HFIP/TEA vs TMAA. In fact,
TMAA at 120 mM pH 7.4 roughly consists of equimolar
amounts of trimethylamine (pKb 4.2) and acetic acid (pKa 4.8);
in contrast, the amount of triethylamine (pKb 3.3) necessary to
neutralize a solution of 120 mM-HFIP (pKa 9.3) is considerably
lower (<5 mM), yielding a relatively low concentration of
triethylammonium salt. This low salt concentration on one
hand reduces the neutralization of the phosphate groups and
thus increases the DNA charge states detected by ESI-MS; on
the other, it reduces signal suppression hence raising the ESI
signal intensity.31 Thus, while in general terms multicharging of
biomolecules depicts denaturation, in this case the salt eﬀect
increases G4 conformation and MS detection, as corroborated
by CD analysis (Figure 1a) and MS detection of coordinated
K+ ions (Figure 1b and Figure S2) and of G4-bound ligand
(Figure 2a,b and Figure S3).
We next compared detection of G4-ligand complexes in
TEA/HFIP vs TMAA. BRACO-19 (B19) was used as a
reference ligand, since it has been shown to interact with most
G4s and, in particular, with all those used in this study.8,12,33,34
When B19 was added to LTR-IV at 1:2 G4/B19 molar ratio in
0.8 mM K+, 20% IPA, and 120 mM TEA/HFIP, molecular
masses corresponding to LTR-IV with both one and two bound
B19 molecules were detected. The base peak corresponding to
LTR-IV/2K+/1B19 had a charge state 7− (Figure 2a and
Figure S3b). In contrast, in 120 mM TMAA, only the complex
with one B19 was observed (LTR-IV/2K+/1B19), the base
peak charge state was 4− and the intensity ∼10-fold lower
(Figure 2a and Figure S3a). We next checked the degree of
speciﬁc binding obtainable in TEA/HFIP: we tested the
binding of B19 to hTel, which in TEA/HFIP is present both as
G4-folded and unfolded DNA. In the presence of B19, only K+-
adducts (1K+ and 2K+) bound to B19 were found, while no
B19 was detected bound to the free unstructured DNA,
indicating that a stringent speciﬁcity of binding was maintained
in TEA/HFIP (Figure 2b and Figure S3c). Because signal
intensity in TEA/HFIP was very high, we tested the possibility
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to analyze diluted samples: LTR-IV + 2K+ either free or bound
to one molecule of B19 was detected at G4 concentration as
low as 40 nM (Figure S4c). At higher concentration (i.e., 400
nM, 4 μM) LTR-IV + 2K+ with two molecules of B19 was also
detected (Figure S4a,b). The increased sensitivity in TEA/
HFIP allows decreasing the concentration of both target
molecule and ligand minimizing aspeciﬁc binding, if present.
■ CONCLUSIONS
The possibility to increase MS signal intensity without aﬀecting
physiological folding enables the analysis of G4s and G4-small
molecule adducts in the submicromolar range. This feature can
be exploited for high-throughput screening of complex mixtures
of ligands on a folded nucleic acid scaﬀold and therefore for the
development of drug molecules eﬀective against signiﬁcant
human diseases.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.anal-
chem.7b01282.
Oligonucleotides used in this study; dichroic spectra of
the tested G4 forming oligonucleotides; ESI-MS full
spectra of the zoomed in spectra shown in Figure 1b;
ESI-MS full spectra of the zoomed in spectra shown in
Figure 2; and ESI-MS spectra of decreasing amounts of
LTR-IV with B19 (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: sara.richter@unipd.it.
ORCID
Sara N. Richter: 0000-0002-5446-9029
Author Contributions
The manuscript was written through contributions of all
authors. All authors have given approval to the ﬁnal version of
the manuscript.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work was supported by the Bill and Melinda Gates
Foundat ion (GCE Grant Numbers OPP1035881,
OPP1097238) and the European Research Council (ERC
Consolidator Grant 615879). Helpful discussions with Dr. M.
Bellini and Dr. D. Dalzoppo are gratefully acknowledged.
■ REFERENCES
(1) Williamson, J. R.; Raghuraman, M. K.; Cech, T. R. Cell 1989, 59,
871−880.
(2) Wang, Y.; Patel, D. J. Biochemistry 1992, 31, 8112−8119.
(3) Phan, A. T.; Kuryavyi, V.; Patel, D. J. Curr. Opin. Struct. Biol.
2006, 16, 288−298.
(4) Huppert, J. L.; Balasubramanian, S. Nucleic Acids Res. 2007, 35,
406−413.
(5) Beaume, N.; Pathak, R.; Yadav, V. K.; Kota, S.; Misra, H. S.;
Gautam, H. K.; Chowdhury, S. Nucleic Acids Res. 2013, 41, 76−89.
(6) Metifiot, M.; Amrane, S.; Litvak, S.; Andreola, M.-L. Nucleic Acids
Res. 2014, 42, 12352−12366.
(7) Perrone, R.; Nadai, M.; Poe, J. A.; Frasson, I.; Palumbo, M.; Palu,̀
G.; Smithgall, T. E.; Richter, S. N. PLoS One 2013, 8, e73121.
(8) Perrone, R.; Nadai, M.; Frasson, I.; Poe, J. A.; Butovskaya, E.;
Smithgall, T. E.; Palumbo, M.; Palu,̀ G.; Richter, S. N. J. Med. Chem.
2013, 56, 6521−6530.
(9) Taylor, J. P. Nature 2014, 507, 175−177.
(10) Murat, P.; Zhong, J.; Lekieffre, L.; Cowieson, N. P.; Clancy, J.
L.; Preiss, T.; Balasubramanian, S.; Khanna, R.; Tellam, J. Nat. Chem.
Biol. 2014, 10, 358−364.
(11) Artusi, S.; Perrone, R.; Lago, S.; Raffa, P.; Di Iorio, E.; Palu,̀ G.;
Richter, S. N. Nucleic Acids Res. 2016, 44, 10343−10353.
(12) Artusi, S.; Nadai, M.; Perrone, R.; Biasolo, M. A.; Palu,̀ G.;
Flamand, L.; Calistri, A.; Richter, S. N. Antiviral Res. 2015, 118, 123−
131.
(13) Bidzinska, J.; Cimino-Reale, G.; Zaffaroni, N.; Folini, M.
Molecules 2013, 18, 12368−12395.
(14) Perrone, R.; Butovskaya, E.; Daelemans, D.; Palu, G.;
Pannecouque, C.; Richter, S. N. J. Antimicrob. Chemother. 2014, 69,
3248−3258.
(15) Perrone, R.; Doria, F.; Butovskaya, E.; Frasson, I.; Botti, S.;
Scalabrin, M.; Lago, S.; Grande, V.; Nadai, M.; Freccero, M.; Richter,
S. N. J. Med. Chem. 2015, 58, 9639−9652.
(16) Rosu, F.; De Pauw, E.; Gabelica, V. Biochimie 2008, 90, 1074−
1087.
(17) Rosu, F.; Gabelica, V.; Houssier, C.; Colson, P.; Pauw, E. D.
Rapid Commun. Mass Spectrom. 2002, 16, 1729−1736.
(18) Li, H.; Liu, Y.; Lin, S.; Yuan, G. Chem. - Eur. J. 2009, 15, 2445−
2452.
(19) Smargiasso, N.; Rosu, F.; Hsia, W.; Colson, P.; Baker, E. S.;
Bowers, M. T.; De Pauw, E.; Gabelica, V. J. Am. Chem. Soc. 2008, 130,
10208−10216.
(20) Pierce, S. E.; Wang, J.; Jayawickramarajah, J.; Hamilton, A. D.;
Brodbelt, J. S. Chem. - Eur. J. 2009, 15, 11244−11255.
(21) Evans, S. E.; Mendez, M. A.; Turner, K. B.; Keating, L. R.;
Grimes, R. T.; Melchoir, S.; Szalai, V. A. JBIC, J. Biol. Inorg. Chem.
2007, 12, 1235−1249.
(22) Marchand, A.; Gabelica, V. J. Am. Soc. Mass Spectrom. 2014, 25,
1146−1154.
(23) De Nicola, B.; Lech, C. J.; Heddi, B.; Regmi, S.; Frasson, I.;
Perrone, R.; Richter, S. N.; Phan, A. T. Nucleic Acids Res. 2016, 44,
6442−6451.
Figure 2. ESI-MS spectra of G4s in the presence of BRACO-19 in
diﬀerent buﬀers. (a) LTR-IV was incubated with 2 equivalents of B19
in 0.8 mM K+, 20% IPA, and either TMAA 120 mM pH 7.4 (left
panel) or TEA/HFIP 120 mM pH 7.4 (right panel). (b) HTel 4 μM in
the absence (left panel) or presence (right panel) of 1 equiv of B19 in
TEA/HFIP 120 mM pH 7.4, 0.8 mM KCl, and 20% IPA. The red X
symbols indicate the absence of adducts between the unstructured
hTel and B19.
Analytical Chemistry Technical Note
DOI: 10.1021/acs.analchem.7b01282
Anal. Chem. 2017, 89, 8632−8637
8636
(24) Wang, Y.; Patel, D. J. Structure 1993, 1, 263−282.
(25) Siddiqui-Jain, A.; Grand, C. L.; Bearss, D. J.; Hurley, L. H. Proc.
Natl. Acad. Sci. U. S. A. 2002, 99, 11593−11598.
(26) Randazzo, A.; Spada, G. P.; da Silva, M. W. In Quadruplex
Nucleic Acids; Chaires, J. B., Graves, D., Eds.; Springer Berlin
Heidelberg: Berlin, Heidelberg, Germany, 2012; Vol. 330, pp 67−86.
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